%20(1).jpg)
.jpg.jpeg)
Cupid Limited Receives CE (EU IVDR) Certification for HIV 1&2 and Hepatitis B IVD Test Kits, Expanding Global Market Access in Diagnostics
Cupid Limited, (BSE – 530843, NSE – CUPID), a diversified Indian healthcare and consumer products company with a growing focus on in-vitro diagnostics (IVD),wellness, and personal care, announced that it has received CE (EU IVDR) Certification for two in-vitro diagnostic (IVD) products – the CupiKIT HIV 1&2 Antibody Test Kit and the CupiKITHepatitis B Surface Antigen (HBsAg) Test Kit. The certifications [...]
Cupid Limited, (BSE – 530843, NSE – CUPID), a diversified Indian healthcare and consumer products company with a growing focus on in-vitro diagnostics (IVD),wellness, and personal care, announced that it has received CE (EU IVDR) Certification for two in-vitro diagnostic (IVD) products – the CupiKIT HIV 1&2 Antibody Test Kit and the CupiKITHepatitis B Surface Antigen (HBsAg) Test Kit.
The certifications have been granted under the European Union In Vitro Diagnostic Regulation (EU) 2017/746 (IVDR), among the most stringent regulatory standards globally. These approvals enable Cupid Limited to market the certified products across the European Economic Area (EEA) and other CE-recognized international markets.
The approvals mark a key milestone in Cupid’s strategy to build a globally compliant and diversified rapid diagnostics portfolio. The addition of HIV 1&2 and Hepatitis B test kits strengthens the Company’s footprint in infectious disease diagnostics, complementing its existing focus on maternal health and screening solutions.
.jpg)
